TAGCyx Biotechnologies uses its proprietary Xenoligo technology platform to generate novel DNA aptamers containing an artificial nucleotide that have high affinity and selectivity for target proteins.

More information: June H. Tan et al, Quantifying metabolites using structure-switching aptamers coupled to DNA sequencing, Nature Biotechnology (2025). DOI: 10.1038/s41587-025-02554-7 Journal ...